key: cord-0812192-xhv93dpv authors: Wang, Julia Y.; Roehrl, Michael W.; Roehrl, Victor B.; Roehrl, Michael H. title: A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases date: 2022-02-25 journal: J Transl Autoimmun DOI: 10.1016/j.jtauto.2022.100147 sha: bac1830cf50e7e8bf3f04478fc7063ea0f484eab doc_id: 812192 cord_uid: xhv93dpv Chronic and debilitating autoimmune sequelae pose a grave concern for the post-COVID-19 pandemic era. Based on our discovery that the glycosaminoglycan dermatan sulfate (DS) displays peculiar affinity to apoptotic cells and autoantigens (autoAgs) and that DS-autoAg complexes cooperatively stimulate autoreactive B1 cell responses, we compiled a database of 751 candidate autoAgs from six human cell types. At least 657 of these have been found to be affected by SARS-CoV-2 infection based on currently available multi-omic COVID data, and at least 400 are confirmed targets of autoantibodies in a wide array of autoimmune diseases and cancer. The autoantigen-ome is significantly associated with various processes in viral infections, such as translation, protein processing, and vesicle transport. Interestingly, the coding genes of autoAgs predominantly contain multiple exons with many possible alternative splicing variants, short transcripts, and short UTR lengths. These observations and the finding that numerous autoAgs involved in RNA-splicing showed altered expression in viral infections suggest that viruses exploit alternative splicing to reprogram host cell machinery to ensure viral replication and survival. While each cell type gives rise to a unique pool of autoAgs, 39 common autoAgs associated with cell stress and apoptosis were identified from all six cell types, with several being known markers of systemic autoimmune diseases. In particular, the common autoAg UBA1 that catalyzes the first step in ubiquitination is encoded by an X-chromosome escape gene. Given its essential function in apoptotic cell clearance and that X-inactivation escape tends to increase with aging, UBA1 dysfunction can therefore predispose aging women to autoimmune disorders. In summary, we propose a model of how viral infections lead to extensive molecular alterations and host cell death, autoimmune responses facilitated by autoAg-DS complexes, and ultimately autoimmune diseases. Overall, this master autoantigen-ome provides a molecular guide for investigating the myriad of autoimmune sequalae to COVID-19 and clues to the rare but reported adverse effects of the currently available COVID vaccines. Autoimmune disorders are ancould be an important feature of the disease manifestations of and long-COVID syndromes [1] . Based on the insights we gained from numerous COVID-related autoantigens (autoAgs) and their associated cellular process and pathways [2] [3] [4] [5] [6] , we propose a model to explain how viral infections in general and SARS-CoV-2 in particular can lead to a wide array of autoimmune diseases (Fig. 1) . We illustrate how viral infections lead to extensive molecular alterations in the host cell, host cell death and tissue injury, autoimmune reactions, and the eventual development of autoimmune diseases. During infections, opportunistic viruses have to hijack the host cell machinery in order to transcribe and translate the viral genes, synthesize viral proteins with correct polypeptide folding and post-translational modifications, and assemble viral particles. At the same time, viruses have to manipulate the host's immune defense to avoid elimination. This intricate host-virus symbiosis is accomplished by extensive alterations of host molecules and reprogramming of host molecular networks. The infected host cells undergo extreme stress and ultimately die, which releases altered molecules (i.e., potential autoAgs) that the immune system may recognize as non-self. In response, the host also synthesizes a cascade of molecules such as dermatan sulfate (DS) to facilitate wound healing and dead cell clearance. We have discovered previously that DS possesses peculiar affinity for apoptotic cells and their released autoAgs [7] [8] [9] [10] . DS, a major component of the extracellular matrix and connective tissue, is increasingly expressed during tissue injury and accumulates in wound areas [2, 11] . Because of their affinity, DS and autoAgs form macromolecular complexes which cooperatively activate autoreactive B1 cells. AutoAg-DS complexes may activate B1 cells via a dual binding mode, i.e., with autoAg binding to the variable region of the B1 cell's autoBCR and DS binding to the heavy chain of the autoBCR. Upon entering B1 cells, DS may regulate immunoglobulin (Ig) production by engaging the Ig-processing complex in the endoplasmic reticulum and the transcription factor GTF2I necessary for Ig gene expression [9, 10] . AutoAg-DS affinity therefore defines a unifying biochemical and immunological property of autoAgs: any self-molecule possessing DS-affinity has a high propensity to become autoantigenic, and this has led to the identification of numerous autoAgs [8, [12] [13] [14] . Among the 657 COVID-affected DS-affinity proteins, 369 (56%) are thus far confirmed autoAgs, accounting for 92% of the 400 confirmed autoAgs of the master autoantigen-ome. This vast number of perturbed autoAgs demonstrates that COVID-19 could lead to a wide variety of autoimmune diseases. For example, 42 autoAgs are associated with the myelin sheath and many are associated with other components of the nervous system, as we have described previously, which may help explain a myriad of neurological symptoms caused by COVID-19 [2] . As another example, 11 autoAgs are related to stress fibers (contractile actin filament bundles consisting of short actin filaments with alternating polarity) and 25 proteins are associated with myofibrils (contractile elements of skeletal and cardiac muscle), which may explain various muscular and cardiomuscular sequelae of COVID-19. A few autoAgs also interact with multiple viral proteins of SARS-CoV-2, suggesting that they play important roles in COVID-19 and merit further investigation. For example, ESYT1 and MOV10 interact with 12 viral proteins, CALU interacts with 11, HSPA5 interacts with 9, COPG1 and ARHGAP1 interact with 8, PLD3 and MARCKS interact with 7, and IDE interacts with 6 viral proteins (Table 1) . PLD3 (a phospholipase) influences the processing of amyloid-beta precursor protein and is associated with spinocerebellar ataxia and Alzheimer's disease. IDE (insulin-degrading enzyme) degrades intracellular insulin and is associated with diabetes. To further understand the autoantigen-ome, we mapped the coding genes for 751 proteins of the master autoantigen-ome, and they are distributed over all chromosomes (Fig. 7 ). Since these include both confirmed and putative autoAgs, one may argue that some of the putative autoAgs may not be true and the gene characteristics may not be meaningful. Therefore, we also mapped the genes for the 400 confirmed autoAgs, and they are similarly distributed over all chromosomes (Fig. 7) . For both confirmed and putative autoAgs, coding gene prevalence is significantly higher on chromosomes 11, 12, 17 , and 19, lower on chromosome 18, and almost absent on chromosome Y (Fig. 7) . Various cluster loci are noticeable, e.g., on chromosomes 1, 11, 12, 17, and 19. Intriguingly, autoAg coding genes contain significantly larger numbers of exons than expected, with the majority containing at least 4 exons (Fig. 8 ). The number of transcript isoforms per coding gene is also significantly skewed towards higher numbers, and those with ≥6 isoforms are particularly dominant. Furthermore, the lengths of coding sequence, transcript, and 3' and 5'-UTR of autoAg coding genes are skewed towards shorter sizes relative to the distribution of all coding genes (Fig. 8) . We also examined the coding genes of the 400 confirmed autoAgs, and they show similar dominance in higher number ofexons and -isoforms, shorter transcripts, and shorter 3'-UTR lengths (Fig. 8) . The predominance of multiple exons and transcript variants suggests a role for RNA processing and alternative splicing in the origination of autoAgs. For genes with multiple exons, alternative splicing can yield a range of unique protein isoforms by varying the exon composition. Curiously, numerous components of the splicing machinery are well-known nuclear autoAgs. In fact, this study identified 120 potential autoAgs associated with RNA processing and 70 potential autoAgs associated with RNA splicing (Table 1 and Figs. [2] [3] . The majority of these have been found to be affected by SARS-CoV-2 infection (Figs. [5] [6] . During splicing, a group of snRNPs (small nuclear ribonucleoproteins) bind to the intron of a newly formed pre-mRNA and splice it to result in a mature mRNA. Ten snRNP autoAgs are identified by DSaffinity, 8 of which have been found to be affected by SARS-CoV-2 infection (Table 1) . During splicing, snRNAs undergo conformational rearrangements that are catalyzed by the DEAH/DEAD box superfamily of RNA helicases. 11 such helicases are identified by DS-affinity, and 10 have been found to be affected by the viral infection (Table 1) . Serine/arginine-rich splicing factors, such as SRSF1 (also known as alternative splicing factor 1), are sequence-specific splicing factors involved in pre-mRNA splicing. 9 SRSF proteins are identified by DS-affinity, with 7 found to be affected by the viral infection. Seven additional splicing factors are identified by DS-affinity (e.g., poly(U)-binding splicing factor PUF60), with all found to be affected by SARS-CoV-2 infection. Heterogeneous nuclear ribonucleoproteins (hnRNPs) play various roles in gene transcription and post-transcriptional modification of pre-mRNA, e.g., binding pre-mRNAs to render splice sites more or less accessible to the spliceosome and suppressing RNA splicing at a particular exon. 19 hnRNP proteins are identified by DS-affinity, with 17 found affected by SARS-CoV-2 infection. The large number of autoAgs of the RNA splicing machinery and their involvement in SARS-CoV-2 infection provide support to the notion that viral infections exploit alternative splicing. It is logical to speculate that viruses hijack the splicing machinery to force the host to synthesize virus-beneficial protein isoforms and thereby reprogram the host cellular protein network so that the virus can survive and replicate. It is also plausible that protein isoforms from virus-induced alternative splicing are recognizable by our immune system as unusual and non-self and hence may trigger an (auto)immune response. Various studies have reported alternative splicing among autoAgs. For example, an informatics analysis of 45 autoAgs showed that alternative splicing occurred in 100% of the transcripts, which was significantly higher than the ~42% rate observed in a randomly selected set of 9,554 gene transcripts. Furthermore, 80% of the transcripts underwent non-canonical alternative splicing, which was significantly higher than the <1% rate in randomly selected human gene transcripts [39] . As another example, Ro52/SSA is one of the autoAg targets strongly associated with the autoimmune responses in mothers whose children have manifestations of neonatal lupus. The gene for full-length Ro52 spans 10 kb of DNA and contains 7 exons, and an alternatively spliced transcript encoding a novel autoAg expressed in the fetal and adult heart has been identified [40] . In a patient with primary Sjörgren syndrome, an alternative mRNA variant of the nuclear autoAg La/SSB was found to result from a promoter switch and alternative splicing [41] . We have consistently found that DS binds apoptotic cells regardless of cell type [7, 9] . To figure out which molecules are involved in this affinity, we searched for DS-affinity proteins shared in all 6 human cell lines of this study and found 39 autoAg candidates (Fig. 9 ). These include 9 ER chaperone complex proteins, 5 14-3-3 proteins, 3 hnRNPs, and 3 tropomyosin proteins. All are known autoAgs except for ANP32A and YWHAB (14-3-3 alpha/beta). Given that ANP32A's paralog ANP32B and 5 other 14-3-3 isoforms are known autoAgs, it is likely they are also true autoAgs. Remarkably, several classical ANA (antinuclear antibody) autoAgs that define systemic autoimmune diseases are among the autoAgs found in the DS-affinity proteomes of all 6 human cell lines, including histone H1 and H4, SSB/ (lupus La), XRCC5/Ku80, XRCC6/Ku70, and PCNA. Because these autoAgs are commonly found in apoptotic cells, it is not surprising that autoimmune responses targeting these autoAgs tend to be systemic; in other words, they all are potential markers of systemic autoimmune diseases. Based on GO Biological Process and Reactome Pathway analysis, 22 of the common autoAgs are associated with cellular responses to stress, 17 are associated with regulation of apoptotic processes, and 8 are markers of apoptosis (Fig. 9 ). Moreover, these common autoAgs are involved in chromosome organization (ANP32A, ANP32B, H1-2, H4, KPNB1, NPM1, PCNA, SET, XRCC5, XRCC6), cytoskeleton organization (ACTN1, CALR, TPM1, TPM3, TPM4, TUBA1C, VIM) , and mitochondrial membrane organization (YWHAB, YWHAE, YWHAG, YWHAQ, YWHAZ). These findings reveal that apoptosis is accompanied by reorganization of the nucleus, mitochondria, and cytoskeleton. Among the above common autoAgs, UBA1 (or UBE1, ubiquitin-like modifier-activating enzyme 1) plays an essential role in dead cell clearance. UBA1 catalyzes the first step in ubiquitination -the "kiss of death" -that marks cellular proteins for degradation. It has long been speculated that dysregulation of apoptotic pathways and dysfunctional clearance of dead cells are among the main causes of autoimmunity, which is in line with our findings [7, 9] . Apoptosis also directly contributes to the maintenance of lymphocyte homeostasis and the deletion of autoreactive cells. Therefore, dysfunction of UBA1 could result in deficient clearance of apoptotic cells and aberrant autoimmunity. Recently, UBA1 somatic mutations have been linked to a severe adult-onset autoinflammatory disease termed VEXAS syndrome [42] . A somatic mutation affecting methionine-41 in UBA1 results in a loss of the canonical cytoplasmic isoform of UBA1 and in the expression of a novel catalytically impaired isoform. Additionally, mutant peripheral blood cells show decreased ubiquitination and activated innate immune pathways. Strikingly, UBA1 protein expression is found up-regulated at different time points of SARS-CoV-2 infection, whereas two deubiquitinating enzymes, USP9X and USP5, are down-regulated [32] (Supplemental Table 1 ). Furthermore, among the 657 proteins of the COVID autoantigen-ome, 178 have been found to be affected by ubiquitination (Fig. 10 ). They are most significantly associated with RNA metabolism and cellular response to stress. In addition, ubiquitination affects proteins involved in signaling by Rho GTPase, RNA splicing, translation, protein folding, nonsense-mediated decay, DNA damage stress-induced senescence, and the cytoskeleton. These findings underline the extensive involvement of ubiquitination in viral infection. UBA1 is coded by the UBA1 gene located on the X chromosome with no homolog on the Y chromosome, and more importantly, UBA1 can escape X-chromosome inactivation. UBA1 appears to be protected against chromosome-wide transcriptional silencing by a chromatin boundary flanked by histone H3 modifications and CpG hypomethylation [43] . In human female fibroblasts, UBA1 mRNA is detected from both the active and inactive X chromosomes, and UBA1 is expressed in a large panel of somatic cell hybrids retaining inactive X chromosomes [44] . In human endothelial cells from dizygotic twins, UBA1 and a few other X-chromosome encoded proteins are expressed at higher levels in female cells [45] . UBA1 expression is estimated to be ~ 60% from X-active alleles, 30% biallelic, and 10% from X-inactive alleles [46] . X-linked genes, particularly escape genes, contribute to sex differences. In women, about 15% of Xlinked genes are bi-allelically expressed, and expression from the inactive X allele varies from a few percent to near equal to that of the active allele [47] . X-inactivation and escape may enhance phenotypic differences between females and males and may also enhance variability within females due to mosaicism from cells with the X-maternal or X-paternal inactivated and to a variable degree of escape from X-inactivation [47] . Aging, which is associated with telomere shortening, can relax X-inactivation and force global transcriptome alterations [48] , which may lead to gene escape and altered expression of UBA1. Therefore, dysfunction of UBA1 due to X-inactivation escape may predispose women, particularly aging women, to increasing dysfunctional regulation of apoptosis and aberrant autoimmunity. To understand the various rare but reported side effects from the currently available viral vector-and mRNA-encoded S-protein COVID vaccines, we searched for autoAgs that may interact with the spike protein of SARS-CoV-2 and found 15 autoAg candidates ( Table 2 ). Of these, CALU, ESYT1, MOV10, and MARCKS may also interact with many other SARS-CoV-2 proteins as discussed earlier. Curiously, at least 2 of these are associated with blood clotting problems, and 5 are implicated in neurological disorders (Table 2 ). For example, CALU (calumenin) is a calcium-binding protein and is expressed in high levels in the heart, placenta, and skeletal muscle. CALU is associated with pharmacodynamics and response to elevated platelet cytosolic Ca 2+ , platelet degranulation, and Coumarin/Warfarin resistance. Warfarin is an anticoagulant (blood thinner) drug used to treat blood clots such as deep vein thrombosis and pulmonary embolism and to prevent stroke in people with heart problems such as atrial fibrillation, valvular heart disease or in people with artificial heart valves. Although largely speculative at present, these potential S-protein-interacting autoAgs may provide partial explanations for the rare hematological, neurological, and muscular side effects reported for the currently available COVID vaccines ( Table 2) . Although it is known that S proteins are synthesized intracellularly following vaccination with mRNAs or viral vectors, many of the precise molecular steps remain unknown. In particular, how do these newly synthesized S proteins fold and are they glycosylated differently depending on the cell type that rakes up the mRNA or the viral vector? How does the newly synthesized S protein interact with other host cell components before being processed (or degraded) and presented to immune cells? For example, could the nascent S proteins interact with CALU or ESYT1 to cause blood clotting problems, could S protein interaction with HSPA5 contributes to fungal infection outbreaks as seen in India? These and many other questions await further investigation. This is of interest because mRNA and vector-based vaccines make use of a variety of cell types in vivo to produce the immunogen, whereas recombinant protein-based vaccines introduce the ex vivo prepared immunogen directly to the immune system. In addition, this study identified a large number of autoAg candidates that are crucial for vector-based or mRNA vaccine action, including translation, RNA processing and metabolism, vesicles and vesiclemediated transport, and protein processing and transport ( In this report, we compiled a master autoantigen-ome of 751 potential autoAgs, 657 of which are affected in SARS-CoV-2 infection, and 400 of which are confirmed autoAgs in a wide variety of autoimmune diseases and cancer. Our proposed model (Fig. 1 ) provides a plausible explanation for how a cascade of molecular changes associated with viral infection leads to cell stress, apoptosis, and subsequent autoimmune responses. The large number of autoAg candidates associated with SARS-CoV-2 infection provides a mechanistic rationale for the close monitoring of autoimmune diseases that may follow the COVID-19 pandemic. In addition, the coding gene characteristics of autoAgs described in this study provide further insights into the genetic origination of autoAgs. The significance of ubiquitination in apoptotic cell clearance and protein turnover and the X-linked escape expression of UBA1 might explain, in part, the predisposition of aging women to autoimmune diseases. [33] W. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19. bioRxiv An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19 An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19. bioRxiv An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19. bioRxiv An Autoantigen Profile from Jurkat T-Lymphoblasts Provides a Molecular Guide for Investigating Autoimmune Sequelae of COVID-19. bioRxiv Dermatan sulfate interacts with dead cells and regulates CD5(+) B-cell fate: implications for a key role in autoimmunity Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens Dermatan Sulfate Is a Potential Regulator of IgH via Interactions With Pre-BCR, GTF2I, and BiP ER Complex in Pre-B Lymphoblasts Dermatan Sulfate Is a Potential Master Regulator of IgH via Interactions with Pre-BCR, GTF2I, and BiP ER Complex in Pre-B Lymphoblasts. bioRxiv Glycosaminoglycans are a potential cause of rheumatoid arthritis A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins Metascape provides a biologist-oriented resource for the analysis of systems-level datasets Single-cell landscape of immunological responses in patients with COVID-19 Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection Proteomics of SARS-CoV-2-infected host cells reveals therapy targets A singlecell atlas of the peripheral immune response in patients with severe COVID-19 In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing The Global Phosphorylation Landscape of SARS-CoV-2 Infection Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 Proteomic and Metabolomic Characterization of COVID-19 SARS-CoV-2 productively infects human gut enterocytes A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerging microbes & infections Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerging microbes & infections Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV. bioRxiv Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms STRING v11: proteinprotein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets ShinyGO: a graphical gene-set enrichment tool for animals and plants Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes 52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart Different La/SS-B mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjögren's syndrome Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease Inactive X chromosome-specific histone H3 modifications and CpG hypomethylation flank a chromatin boundary between an X-inactivated and an escape gene X inactivation analysis and DNA methylation studies of the ubiquitin activating enzyme E1 and PCTAIRE-1 genes in human and mouse Sex-specific differences in the intracellular proteome of human endothelial cells from dizygotic twins Landscape of X chromosome inactivation across human tissues Genes that escape from X inactivation Telomere shortening relaxes X chromosome inactivation and forces global transcriptome alterations Alterations in antibody subclass immune reactivity to trophoblast-derived fetal fibronectin and α2-macroglobulin in women with recurrent pregnancy loss Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis Detection of citrate synthasereacting autoantibodies after heart transplantation: an epitope mapping study. Transplant international : official journal of the European Society for Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity Identification and validation of candidate biomarkers involved in human ovarian autoimmunity The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and beta-actin An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins Autoantibodies in three populations of Burkitt's lymphoma patients Glomerular antibodies in lupus nephritis CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach Plasma IgG autoantibody against actin-related protein 3 in liver fluke Opisthorchis viverrini infection Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study Moesin and stressinduced phosphoprotein-1 are possible sero-diagnostic markers of psoriasis Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach Autoimmunity in membranous nephropathy targets aldose reductase and SOD2 Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves' orbitopathy Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders Identification of anti-retinal antibodies in patients with age-related macular degeneration Comparison of candidate serologic markers for type I and type II ovarian cancer Autoantibodies against BAFF, APRIL or IL21 -an alternative pathogenesis for antibody-deficiencies? Proteomic profiling of antibody-inducing immunogens in tumor tissue identifies PSMA1, LAP3, ANXA3, and maspin as colon cancer markers Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis Detection of antiannexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus A case of neonatal lupus erythematosus presenting delayed dilated cardiomyopathy with circulating autoantibody to annexin A6 Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity Antibodies against ARHGDIB are associated with long-term kidney graft loss Cyclic Peptide Mimotopes for the Detection of Serum Anti-ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma Epitope Mapping of SERCA2a Identifies an Antigenic Determinant That Induces Mainly Atrial Myocarditis in A/J Mice Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases Identification of Cell Surface Straight Chain Poly-N-Acetyl-Lactosamine Bearing Protein Ligands for VH4-34-Encoded Natural IgM Antibodies Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) Antibody that recognizes conformations of calmodulin in the serum from patient with chronic active hepatitis Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome. Translational research : the journal of laboratory and clinical medicine Immunological characterization of heterochromatin protein p25beta autoantibodies and relationship with centromere autoantibodies and pulmonary fibrosis in systemic scleroderma Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteins Serum antibody response to group II chaperonin from Methanobrevibacter oralis and human chaperonin CCT Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor beta pathway in patients with systemic sclerosis Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology Anti-retinal antibodies in patients with macular telangiectasia type 2 Identification of autoantibodies expressed in acquired aplastic anaemia Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis? Annals of the rheumatic diseases Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome Antitype II collagen antibodies detection and avidity in patients with oligoarticular and polyarticular forms of juvenile idiopathic arthritis Antibodies to collagen in patients with idiopathic pulmonary fibrosis Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection. Current opinion in organ transplantation Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays Clinical association of antigolgi autoantibodies and their autoantigens Identification of coronin-1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis The COOH-terminal Src kinase Csk is a tumor antigen in human carcinoma Non-selfdiscrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome Drebrin Autoantibodies in Patients with Seizures and Suspected Encephalitis Differential switching to IgG and IgA in active smoking COPD patients and healthy controls Molecular characterization of two human autoantigens: unique cDNAs encoding 95-and 160-kD proteins of a putative family in the Golgi complex Unique epitopes in RNA helicase II/Gu protein recognized by serum from a watermelon stomach patient Repetitive P68-autoantigen specific epitopes recognized by human anti-(U1) small nuclear ribonucleoprotein autoantibodies Do we need new autoantibodies in lupus? Arthritis research & therapy Proteomic identification of dihydrolipoamide dehydrogenase as a target of autoantibodies in patients with endometrial cancer Inhibition of alpha-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis Autoantibody to heat shock protein Hsp40 in sera of lung cancer patients Identification of chronic brain protein changes and protein targets of serum auto-antibodies after blast-mediated traumatic brain injury Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 α1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults Identification of autoantibodies elicited in a patient with prostate cancer presenting as dermatomyositis Anti-elongation factor-1alpha autoantibody in adult atopic dermatitis patients Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer 20S small nuclear ribonucleoprotein U5 shows a surprisingly complex protein composition Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling Augmentation of Autoantibodies by Helicobacter pylori in Parkinson's Disease Patients May Be Linked to Greater Severity Evaluation of a panel of tumor-associated antigens in breast cancer. Cancer biomarkers : section A of Disease markers HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders Pituitary autoantibodies in lymphocytic hypophysitis target both gamma-and alpha-Enolase -a link with pregnancy? Archives of physiology and biochemistry Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women Identification of novel autoantigens via mass spectroscopy-based antibody-mediated identification of autoantigens (MS-AMIDA) using immune thrombocytopenic purpura (ITP) as a model disease Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas Fibronectin promotes nasopharyngeal cancer cell motility and proliferation Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach Detection of novel autoantigens in patients with recurrent miscarriage: description of an approach and preliminary findings Anti-GAPDH Autoantibodies as a Pathogenic Determinant and Potential Biomarker of Neuropsychiatric Diseases Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy Identification of the novel autoantigen candidate Rab GDP dissociation inhibitor alpha in isolated adrenocorticotropin deficiency Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes Dominant prostasome immunogens for sperm-agglutinating autoantibodies of infertile men Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer Multi-dimensional immunoproteomics coupled with in vitro recapitulation of oncogenic NRAS(Q61R) identifies diagnostically relevant autoantibody biomarkers in thyroid neoplasia Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies: possible mechanism of autoantibody production Serum autoantibody against glutathione Stransferase in patients with glaucoma Mapping of B-cell epitopes recognized by antibodies to histones in subsets of juvenile chronic arthritis Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus Circulating autoantibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera Variable region genes of human monoclonal autoantibodies to histones H2A and H2B from a systemic lupus erythematosus patient High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis Antibodies to H2a and H2b histones from the sera of HIV-infected patients catalyze site-specific degradation of these histones Apoptosisassociated acetylation on histone H2B is an epitope for lupus autoantibodies Antibodies against H3 and H4 histones from the sera of HIV-infected patients catalyze sitespecific degradation of these histones Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods Heterogenous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases Low Level Antibodies Against Alpha-Tropomyosin Are Associated With Increased Risk of Coronary Heart Disease Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases Identification of Hnrph3 as an autoantigen for acute anterior uveitis Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP P Cell nonhomologous end joining capacity controls SAF-A phosphorylation by DNA-PK in response to DNA double-strand breaks inducers Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease Type 1 diabetes alters anti-hsp90 autoantibody isotype Anti-HSP90 autoantibodies in sera of infertile women identify a dominant, conserved epitope EP6 (380-389) of HSP90 beta protein Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis Anti-HSP70 autoantibody formation by B-1 cells in Toxoplasma gondii-infected mice Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis Development of a sensitive assay for the measurement of antibodies against heat shock protein binding protein 1 (HspBP1): increased levels of anti-HspBP1 IgG are prevalent in HIV infected subjects Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus Autoantibodies to the protein core of vascular basement membrane heparan sulfate proteoglycan in systemic lupus erythematosus The increment of anti-ORP150 autoantibody in initial stages of atheroma in high-fat diet fed mice. The Journal of veterinary medical science Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis Lattwein et al. ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease Importin beta: a novel autoantigen in human autoimmunity identified by screening random peptide libraries on phage Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library RasGAP-like protein IQGAP1 is expressed by human keratinocytes and recognized by autoantibodies in association with bullous skin disease Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades Identification of kinectin as a novel Behçet's disease autoantigen Pregnancy loss and endometriosis: pathogenic role of anti-laminin-1 autoantibodies Differential expression of laminin chains and anti-laminin autoantibodies in experimental lupus nephritis High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis Autismspecific maternal autoantibodies recognize critical proteins in developing brain Serum autoantibody profiling using a natural glycoprotein microarray for the prognosis of early melanoma Anti-galectin-1 autoantibodies in serum of patients with neurological diseases Autoantibodies to lamins A and C in sera of patients showing peripheral fluorescent antinuclear antibody pattern on HEP-2 cells High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome Autoantibodies to human nuclear lamin B2 protein. Epitope specificity in different autoimmune diseases Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis Microtubule-associated protein 1B: Novel paraneoplastic biomarker Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis Major vault protein/lung resistance related protein: a novel biomarker for rheumatoid arthritis Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases Autoantibodies to myosin light chains in the blood as early marker of myocardial injury after aortocoronary bypass surgery Monodisperse magnetic poly(glycidyl methacrylate) microspheres for isolation of autoantibodies with affinity for the 46 kDa form of unconventional Myo1C present in autoimmune patients Characterization of a novel isoform of alpha-nascent polypeptide-associated complex as IgEdefined autoantigen Human anti-asparaginyl-tRNA synthetase autoantibodies (anti-KS) increase the affinity of the enzyme for its tRNA substrate Analysis of the autoimmune epitopes on human testicular NASP using recombinant and synthetic peptides Antibodies against nucleolin in recipients of organ transplants Production and characterization of a monoclonal antibody against the sialidase of Gardnerella vaginalis using a synthetic peptide in a MAP8 format A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis Identification of antigenic proteins associated with trichloroethylene-induced autoimmune disease by serological proteome analysis Characterization of the specificity of a naturally-occurring monoclonal anti-thymocyte autoantibody derived from an unimmunized, neonatal Balb/c mouse Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response Nodal proteins are target antigens in Guillain-Barré syndrome Two major autoantigen-antibody systems of the mitotic spindle apparatus cDNA cloning and characterization of a novel nucleolar protein Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays Identification and structure of activatedplatelet protein-1, a protein with RNA-binding domain motifs that is expressed by activated platelets Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients Autoantibodies against PFDN2 are associated with an increased risk of type 2 diabetes: A case-control study Anti-human protein S antibody induces tissue factor expression through a direct interaction with platelet phosphofructokinase Cerebral adrenoleukodystrophy is associated with loss of tolerance to profilin High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases Detection of D-3-phosphoglycerate dehydrogenase autoantibodies in patients with autoimmune hepatitis: Clinical significance evaluation Paraneoplastic pemphigus: a short review Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex Immunoproteomic identification of antigenic candidate Campylobacter jejuni and human peripheral nerve proteins involved in Guillain-Barré syndrome Autoantibodies against cyclophilin in systemic lupus erythematosus and Lyme disease Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2 Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type Characterization of spermatozoa surface antigens by antisperm antibodies and its influence on acrosomal exocytosis Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i) Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining twodimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis Circulating antibodies to prothymosin alpha in systemic lupus erythematosus PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human Orderly pattern of development of the autoantibody response in (New Zealand White x BXSB)F1 lupus mice: characterization of target antigens and antigen spreading by two-dimensional gel electrophoresis and mass spectrometry Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1 Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus Ezrin, radixin and moesin are possible auto-immune antigens in rheumatoid arthritis Autoantigenicity of Ro/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases Autoantibodies specific for the 20-KDal ribosomal large subunit protein L12 Heterogeneity of ribosomal autoantibodies from human, murine and canine connective tissue diseases Anti-5S RNA/protein (RNP) antibody levels correlate with disease activity in a patient with systemic lupus erythematosus (SLE) nephritis Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens Central nervous system function in systemic lupus erythematosus A small nucleolar RNA is processed from an intron of the human gene encoding ribosomal protein S3 Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement Presence of antieukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis Autoantibodies to sweat glands detected by different methods in serum and in tissue from patients affected by a new variant of endemic pemphigus foliaceus Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosus Prevalence of HSP47 antigen and autoantibodies to HSP47 in the sera of patients with mixed connective tissue disease SET-related cell division autoantigen-1 (CDA1) arrests cell growth Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with antimelanoma differentiation-associated gene 5 antibody Biological autoimmunity screening in hepatitis C patients by anti-HepG2 lysate and anti-heat shock protein 70.1 autoantibodies. European journal of clinical microbiology & infectious diseases : official publication of the Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with scleroderma-polymyositis overlap syndrome Lupus autoantibodies discriminate between the highly homologous Sm polypeptides B/B' and SmN by binding an epitope restricted to B/B' The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases Anti-spectrin in sera containing smooth muscle autoantibodies from patients with chronic active hepatitis Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis The 72-kDa component of signal recognition particle is cleaved during apoptosis Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma Identification of autoantigens specific for systemic lupus erythematosus with central nervous system involvement Small nucleolar RNP scleroderma autoantigens associate with phosphorylated serine/arginine splicing factors during apoptosis High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients HLA-DQ genotype and biochemical characterization of anti-transglutaminase 2 antibodies in patients with type 1 diabetes mellitus in Taiwan Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis Identification and validation of novel serum markers for early diagnosis of endometriosis Anti-endothelial cell antibodies in patients with cerebral small vessel disease Autoantigens of the nuclear pore complex Course of serum autoantibodies in patients after acute angle-closure glaucoma attack Anti-tubulin-alpha-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations Antitubulin antibodies. II. Natural autoantibodies and induced antibodies recognize different epitopes on the tubulin molecule Identification of target antigens of naturally occurring autoantibodies in cerebrospinal fluid Identification of beta-tubulin isoforms as tumor antigens in neuroblastoma Anti-tubulin antibodies in a sensorimotor neuropathy patient alter tubulin polymerization Autoantibody to thioredoxin reductase in an ovarian cancer patient Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis Specific interaction between human kinetochore protein CENP-C and a nucleolar transcriptional regulator The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus Autoantibody-targeted TAAs in pancreatic cancer: A comprehensive analysis Anti-p97/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease? Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer Tryptophanyl-tRNA synthetase as a human autoantigen Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations Idiopathic inflammatory myopathies and the antisynthetase syndrome: a comprehensive review Autoantibody Formation and Mapping of Immunogenic Epitopes against Cold-Shock-Protein YB-1 in Cancer Patients and Healthy Controls Autismspecific maternal autoantibodies recognize critical proteins in developing brain A prospective cohort study of 14-3-3eta in ACPA and/or RF-positive patients with arthralgia Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis. Arthritis & rheumatology Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab MHR acknowledges a Cycle for Survival Innovation Grant, NIH/NCI grants R21 CA251992 and R21 CA263262, and an Investigator Grant from the Neuroendocrine Tumor Research Foundation (NETRF).The work was partially supported by the MSKCC Cancer Center Support Grant P30 CA008748. The funding bodies were not involved in the design of the study and the collection, analysis, and interpretation of data.